20 October 2022 - On 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, Spikevax (elasomeran), for use as a booster dose in individuals aged 12 years and older.
This mRNA vaccine is already provisionally approved for immunisation to prevent COVID-19 in individuals aged 6 months and older and as a booster dose for adults aged 18 years and older.